Review




Structured Review

Proteintech cxcl10
Cxcl10, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 20 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+ELISA+Kit/pm41719890-162-12-14
Average 94 stars, based on 20 article reviews
cxcl10 - by Bioz Stars, 2026-10
94/100 stars

Images

Related Articles

Enzyme-linked Immunosorbent Assay:

Article Title: Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection
Article Snippet: .. The levels of IFN-α, IFN-β, IL-6, CXCL10, and VEGF were measured using the VeriKine-HS Human IFN Alpha All Subtype ELISA Kit (PBL Assay Science, Piscataway, NJ, USA), VeriKine-HS Human IFN Beta Serum ELISA Kit (PBL Assay Science), AuthentiKineTM Human IL-6 ELISA Kit (Proteintech, Rosemont, IL, USA), Human CXCL10/IP-10 ELISA Kit (Proteintech), and AuthentiKineTM Human VEGF ELISA Kit (Proteintech), respectively. ..

Article Title: Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series.
Article Snippet: of vitiligo.. Understanding the pathogenesis of vitiligo has led to the introduction of effective novel drugs in several studies.. Recently, the use of JAK inhibitors has emerged as a promising therapeutic strategy for treating vitiligo.

Article Title: Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure
Article Snippet: .. The levels of IFN-α, IFN-β, IL-6, IL-10, and CXCL10 were measured using the VeriKine-HS Human IFN Alpha All Subtype ELISA Kit (PBL Assay Science, New Jersey, USA), the VeriKine-HS Human IFN Beta Serum ELISA Kit (PBL Assay Science), the AuthentiKineTM Human IL-6 ELISA Kit (Proteintech, Illinois, USA), the AuthentiKineTM Human IL-10 ELISA Kit (Proteintech), and the Human CXCL10/IP-10 ELISA Kit (Proteintech), respectively. ..

Article Title: Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants.
Article Snippet: .. IFN-α levels were measured using the VeriKine-HS Human IFN Alpha All Subtype ELISA Kit (PBL Assay Science, Piscataway, NJ, USA), CXCL10 levels were measured using the Human CXCL10/IP-10 ELISA Kit (Proteintech, Rosemont, IL, USA), IL-6 levels were measured using the AuthentiKineTM Human IL-6 ELISA Kit (Proteintech, Rosemont, IL, USA), and VEGF levels were measured using the Viruses 2023, 15, 1304 4 of 12 AuthentiKineTM Human VEGF ELISA Kit (Proteintech, Rosemont, IL, USA). ..

Article Title: Dominant CT Patterns and Immune Responses during the Early Infection Phases of Different SARS-CoV-2 Variants
Article Snippet: .. IFN-α levels were measured using the VeriKine-HS Human IFN Alpha All Subtype ELISA Kit (PBL Assay Science, Piscataway, NJ, USA), CXCL10 levels were measured using the Human CXCL10/IP-10 ELISA Kit (Proteintech, Rosemont, IL, USA), IL-6 levels were measured using the AuthentiKineTM Human IL-6 ELISA Kit (Proteintech, Rosemont, IL, USA), and VEGF levels were measured using the AuthentiKineTM Human VEGF ELISA Kit (Proteintech, Rosemont, IL, USA). ..

Clinical Proteomics:

Article Title: Repigmentation in non-segmental vitiligo using the Janus kinase inhibitor upadacitinib, a retrospective case series.
Article Snippet: of vitiligo.. Understanding the pathogenesis of vitiligo has led to the introduction of effective novel drugs in several studies.. Recently, the use of JAK inhibitors has emerged as a promising therapeutic strategy for treating vitiligo.



Similar Products

94
Multi Sciences (Lianke) Biotech Co Ltd cxcl10
Cxcl10, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/EasyGo!+Human+CXCL10%2FIP-10+One-Step+ELISA+Kit/pm41577074-231-30-32
Average 94 stars, based on 1 article reviews
cxcl10 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
R&D Systems dip100 quantikine immunoassay
Dip100 Quantikine Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+Quantikine+ELISA+Kit/us12601747-328-9-26
Average 96 stars, based on 1 article reviews
dip100 quantikine immunoassay - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
R&D Systems human cxcl10 elisa kit
The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
Human Cxcl10 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+Quantikine+QuicKit+ELISA/pmc13046659-52-12-16
Average 94 stars, based on 1 article reviews
human cxcl10 elisa kit - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
R&D Systems duoset elisa kits
The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
Duoset Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+DuoSet+ELISA/pm41896548-400-9-16
Average 96 stars, based on 1 article reviews
duoset elisa kits - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
Elabscience Biotechnology human cxcl10 elisa kit
The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
Human Cxcl10 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+IP-10%2FCXCL10+(Interferon+Gamma+Induced+Protein+10kDa)+ELISA+Kit/pm41813910-91-48-52
Average 94 stars, based on 1 article reviews
human cxcl10 elisa kit - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
R&D Systems quantikine elisa kit
The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+Quantikine+ELISA+Kit/pm41714683-112-29-27
Average 96 stars, based on 1 article reviews
quantikine elisa kit - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
Proteintech cxcl10
The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
Cxcl10, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+ELISA+Kit/pm41719890-162-12-14
Average 94 stars, based on 1 article reviews
cxcl10 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
R&D Systems human cxcl10 ip 10 immunoassay
The differences in the expression and clinical correlation of <t>CXCL10</t> were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)
Human Cxcl10 Ip 10 Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+cxcl10+ip+10+elisa+kit/Human+CXCL10%2FIP-10+Quantikine+ELISA+Kit/pm41617975-93-50-56
Average 96 stars, based on 1 article reviews
human cxcl10 ip 10 immunoassay - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


The differences in the expression and clinical correlation of CXCL10 were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)

Journal: Clinical and Experimental Medicine

Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

doi: 10.1007/s10238-026-02126-2

Figure Lengend Snippet: The differences in the expression and clinical correlation of CXCL10 were evaluated in breast cancer patients. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) Differences in the expression of CXCL10 in different types of breast cancer were analyzed with the TIMER2.0 database. ( C ) Based on GEPIA2 breast cancer data, a volcano map was drawn with bioinformatics to determine the expression level of CXCL10. ( D ) The relationship between CXCL10 and the clinical prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. ( F ) The expression differences in different clinical stages were analyzed with the GEPIA2 database. (*** p < 0.001)

Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

Techniques: Expressing, Immunohistochemistry

The composition of cells in the breast cancer tissue microenvironment, interactions between cells, and differences in CXCL10 expression between breast cancer cells and T cells were analyzed with the single-cell sequencing data. ( A - B ) The composition of the main cells in the microenvironment of breast cancer tissue was analyzed with the NGDC database. ( C ) The interaction relationships between various types of cells were analyzed. ( D ) The CXCL10 expression levels were analyzed in various types of cells

Journal: Clinical and Experimental Medicine

Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

doi: 10.1007/s10238-026-02126-2

Figure Lengend Snippet: The composition of cells in the breast cancer tissue microenvironment, interactions between cells, and differences in CXCL10 expression between breast cancer cells and T cells were analyzed with the single-cell sequencing data. ( A - B ) The composition of the main cells in the microenvironment of breast cancer tissue was analyzed with the NGDC database. ( C ) The interaction relationships between various types of cells were analyzed. ( D ) The CXCL10 expression levels were analyzed in various types of cells

Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

Techniques: Expressing, Single Cell, Sequencing

Correlation and differential expression analyses of CXCL10-interacting molecules were performed in BC. ( A ) CXCL10-interacting molecules were analyzed with the String database. ( B - E ) The correlations between CXCL10 and CCL13, CXCL6, PF4V1, and CXCL12 were analyzed with the GEPIA2 database. ( F - I ) Differences in the expression of CCL13, CXCL6, PF4V1 and CXCL12 in breast cancer were analyzed with the GEPIA2 database. ( J ) The differential expression of CXCL10 and CXCL12 in breast epithelial cells and breast cancer cells was detected by western blotting. (* p < 0.05)

Journal: Clinical and Experimental Medicine

Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

doi: 10.1007/s10238-026-02126-2

Figure Lengend Snippet: Correlation and differential expression analyses of CXCL10-interacting molecules were performed in BC. ( A ) CXCL10-interacting molecules were analyzed with the String database. ( B - E ) The correlations between CXCL10 and CCL13, CXCL6, PF4V1, and CXCL12 were analyzed with the GEPIA2 database. ( F - I ) Differences in the expression of CCL13, CXCL6, PF4V1 and CXCL12 in breast cancer were analyzed with the GEPIA2 database. ( J ) The differential expression of CXCL10 and CXCL12 in breast epithelial cells and breast cancer cells was detected by western blotting. (* p < 0.05)

Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

Techniques: Quantitative Proteomics, Expressing, Western Blot

The differences in the expression and clinical correlation of CXCL12 were evaluated in BC patients. ( A ) Differences in CXCL12 expression in different types of breast cancer were analyzed with the TIMER2.0 database. ( B ) Based on GEPIA2 breast cancer data, a volcano map was drawn by bioinformatics to determine the expression of CXCL12. ( C ) Differences in the expression of CXCL12 in different clinical stages were analyzed with the GEPIA2 database. ( D ) The relationship between CXCL12 and the prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E - F ) The expression of CXCL12 in different types of cells was analyzed with single-cell sequencing from the NGDC database. ( G ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. (*** p < 0.001)

Journal: Clinical and Experimental Medicine

Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

doi: 10.1007/s10238-026-02126-2

Figure Lengend Snippet: The differences in the expression and clinical correlation of CXCL12 were evaluated in BC patients. ( A ) Differences in CXCL12 expression in different types of breast cancer were analyzed with the TIMER2.0 database. ( B ) Based on GEPIA2 breast cancer data, a volcano map was drawn by bioinformatics to determine the expression of CXCL12. ( C ) Differences in the expression of CXCL12 in different clinical stages were analyzed with the GEPIA2 database. ( D ) The relationship between CXCL12 and the prognosis of breast cancer patients was analyzed with the TIMER2.0 database. ( E - F ) The expression of CXCL12 in different types of cells was analyzed with single-cell sequencing from the NGDC database. ( G ) The expression level of CXCL10 in adjacent and cancerous tissues was detected by immunohistochemistry. (*** p < 0.001)

Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

Techniques: Expressing, Single Cell, Sequencing, Immunohistochemistry

The impact of CXCL12 on breast cancer and its correlation with CXCL10 were evaluated. ( A ) CXCL12 knockdown efficiency was detected by Q-PCR. ( B - C ) The impact of CXCL12 knockdown on cell invasion ability was detected by transwell assays. ( D - E ) The effect of CXCL12 knockdown on cell migration ability was detected by scratch assays. ( F ) The effect of CXCL12 knockdown on CXCL10 expression was detected by Q-PCR. ( G ) The effect of CXCL12 knockdown on CXCL10 secretion levels was detected by ELISA. (*** p < 0.001)

Journal: Clinical and Experimental Medicine

Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

doi: 10.1007/s10238-026-02126-2

Figure Lengend Snippet: The impact of CXCL12 on breast cancer and its correlation with CXCL10 were evaluated. ( A ) CXCL12 knockdown efficiency was detected by Q-PCR. ( B - C ) The impact of CXCL12 knockdown on cell invasion ability was detected by transwell assays. ( D - E ) The effect of CXCL12 knockdown on cell migration ability was detected by scratch assays. ( F ) The effect of CXCL12 knockdown on CXCL10 expression was detected by Q-PCR. ( G ) The effect of CXCL12 knockdown on CXCL10 secretion levels was detected by ELISA. (*** p < 0.001)

Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

Techniques: Knockdown, Migration, Expressing, Enzyme-linked Immunosorbent Assay

Correlations between CXCL12 and CXCL10 and CD4 + T and CD8 + T cells in the inflammatory microenvironment of breast cancer patients were evaluated, and correlations with the clinical prognosis of breast cancer patients were evaluated. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) The expression levels of CXCL10 and CXCL12 in different types of T lymphocytes were analyzed in different types of breast cancer with the TIMER2.0 database. ( C - F ) The clinical prognosis under different conditions was analyzed with the TIMER2.0 database. ( G ) CD4 + T cells and CD8 + T cells in breast cancer tissues were analyzed by immunofluorescence

Journal: Clinical and Experimental Medicine

Article Title: CXCL12-mediated T cell infiltration drives breast cancer metastasis

doi: 10.1007/s10238-026-02126-2

Figure Lengend Snippet: Correlations between CXCL12 and CXCL10 and CD4 + T and CD8 + T cells in the inflammatory microenvironment of breast cancer patients were evaluated, and correlations with the clinical prognosis of breast cancer patients were evaluated. ( A ) The role of CXCL10 in breast cancer was predicted with the CanerSEA database. ( B ) The expression levels of CXCL10 and CXCL12 in different types of T lymphocytes were analyzed in different types of breast cancer with the TIMER2.0 database. ( C - F ) The clinical prognosis under different conditions was analyzed with the TIMER2.0 database. ( G ) CD4 + T cells and CD8 + T cells in breast cancer tissues were analyzed by immunofluorescence

Article Snippet: After 24 h of incubation, the culture supernatants were analyzed with a human CXCL10 ELISA kit (R&D Systems, QK266).

Techniques: Expressing, Immunofluorescence